Idebenone - Takeda

Drug Profile

Idebenone - Takeda

Alternative Names: Avan; Cerestabon; CV 2619; Daruma; Mnesis

Latest Information Update: 10 Sep 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Takeda
  • Developer Pfizer; Seber; Takeda
  • Class Benzoquinones; Coenzymes; Neuroprotectants; Nootropics; Small molecules
  • Mechanism of Action Antioxidants; Free radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Marketed Alzheimer's disease
  • No development reported Cognition disorders

Most Recent Events

  • 16 Feb 2016 Biomarkers information updated
  • 16 Oct 2009 Wyeth has been acquired by Pfizer
  • 23 Dec 2003 A study has been added to the Alzheimer's disease therapeutic trials section
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top